logo

LEXX

Lexaria Bioscience
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

LEXX fundamentals

Lexaria Bioscience (LEXX) released its earnings on Jul 14, 2025: revenue was 174.00K (YoY +107.14%), beat estimates; EPS was -0.21 (YoY -61.54%), beat estimates.
Revenue / YoY
174.00K
+107.14%
EPS / YoY
-0.21
-61.54%
Report date
Jul 14, 2025
EPS
Revenue

Revenue & Expenses

LEXX has released its 2025 Q3 earnings report, with revenue of 174.00K, reflecting a YoY change of 107.14%, and net profit of -3.79M, showing a YoY change of -112.44%. The Sankey diagram below clearly presents LEXX's revenue sources and cost distribution.

Key Indicators

Lexaria Bioscience (LEXX) key financial stats and ratios, covering profitability, financial health, and leverage.
Lexaria Bioscience (LEXX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Lexaria Bioscience (LEXX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Lexaria Bioscience (LEXX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Lexaria Bioscience (LEXX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Lexaria Bioscience (LEXX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield